Đang chuẩn bị liên kết để tải về tài liệu:
Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The aim of this sub-study is to explore the incidence of skin rash among advanced breast cancer (ABC) patients in a phase II trial treated with weekly nab-paclitaxel and cisplatin combination. |